Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company has developed the "MIMOSA Pro," a portable point-of-care imaging device that uses near-infrared light to non-invasively assess tissue health. It enables early detection of tissue compromise, supports remote monitoring, and aims to improve outcomes by allowing earlier intervention in at-risk patients. The technology has been adopted in clinical settings with positive feedback from clinicians regarding its impact on patient care. No traditional clinical trial results as it’s a medical device/platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MIMOSA Diagnostics.